Skip to content
The Kids Research Institute Australia logo

Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL

Citation:
Chiu SK, Furlong E, Fox A, McKinnon EJ, Ovando SS, McLean-Tooke A, Oommen J, Yeoh DK, Cheung LC, Gottardo NG, Kotecha RS. Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL. Blood Adv. 2026;10(7):2425-8.